Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound Alverine Citrate vs Carvedilol for Portal Hypertension in Cirrhosis
NCT06470386Phase 3Not yet recruiting
- Sponsor
- Shanghai Changzheng Hospital
- Start
- Jun 2024
- Primary completion
- Nov 2025
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of alverine in Portal Hypertension (PH), sponsored by Shanghai Changzheng Hospital. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
alverine
03
Conditions
Portal Hypertension (PH)
Beyond the preview
Go deeper on NCT06470386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06470386.